Notice Concerning Change of Representative Directors
October 24, 2017 Notice Concerning Change of Representative Directors Read more
October 24, 2017 Notice Concerning Change of Representative Directors Read more
October 23, 2017 MORRIS PLAINS, N.J., Oct. 23, 2017 /PRNewswire/ — Honeywell International Inc. (“Honeywell”) (NYSE: HON) today announced that it has commenced four separate private offers to exchange any and all of its outstanding notes listed below (the “Existing Notes”) for a combination of newly issued debt securities of Honeywell and cash (the “Exchange Offers”). The Exchange... Read more
Download PDF Read more
Download PDF Read more
October 19, 2017 04:15 PM Eastern Daylight Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE: WAT) announced today that Douglas A. Berthiaume will retire as Chairman of the Board of Directors of the Company, effective December 31, 2017. The Board of Directors has elected Christopher J. O’Connell, President and Chief Executive Officer, as its new Chairman effective... Read more
GE Healthcare today announced that it has received Carequality certification to enable seamless data sharing by its ambulatory EHR customers with thousands of hospitals, physician practices, payer networks, vendors and consumer services nationally. Already a KLAS top performer for interoperability impact on patient care1, GE Healthcare built upon its existing expertise in providing digital tools... Read more
– Customer data and updated pricing will be presented at the 67th Annual Meeting of the American Society of Human Genetics (ASHG) held in Orlando, FL – PLEASANTON, CA.—October 18, 2017— 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced more affordable pricing for their Chromium™ Genome,... Read more
– New products for profiling adaptive immunity will be presented at the 67th Annual Meeting of the American Society of Human Genetics (ASHG) held in Orlando, FL – PLEASANTON, CA.—October 18, 2017— 10x Genomics, a company focused on enabling the mastery of biology by accelerating genomic discovery, this week will launch new products for their... Read more
ALAMEDA, Calif.–(BUSINESS WIRE)–Oct. 17, 2017– BioTime, Inc. (“BioTime”) (NYSE American and TASE: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced the closing of its previously announced public offering of 9,615,385 shares of common stock, including 1,442,308 shares sold pursuant to the underwriters’ exercise in full of their... Read more